These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 371663)

  • 61. Changes in premenstrual symptoms in women with schizophrenia: a prospective study.
    Choi SH; Kang SB; Joe SH
    Psychosom Med; 2001; 63(5):822-9. PubMed ID: 11573031
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The relationship between mood and sexuality in women using an oral contraceptive as a treatment for premenstrual symptoms.
    Graham CA; Sherwin BB
    Psychoneuroendocrinology; 1993; 18(4):273-81. PubMed ID: 8316616
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The effect of dydrogesterone on premenstrual symptoms. A double-blind, randomized, placebo-controlled study in general practice.
    Hoffmann V; Pedersen PA; Philip J; Fly P; Pedersen C
    Scand J Prim Health Care; 1988 Sep; 6(3):179-83. PubMed ID: 3065875
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Evening primrose oil and treatment of premenstrual syndrome.
    Khoo SK; Munro C; Battistutta D
    Med J Aust; 1990 Aug; 153(4):189-92. PubMed ID: 2201888
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Persistence of premenstrual syndrome during low-dose administration of the progesterone antagonist RU 486.
    Chan AF; Mortola JF; Wood SH; Yen SS
    Obstet Gynecol; 1994 Dec; 84(6):1001-5. PubMed ID: 7970453
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Physical symptoms in premenstrual syndrome are related to plasma progesterone and desoxycorticosterone.
    Seippel L; Eriksson O; Grankvist K; von Shoultz B; Bäckström T
    Gynecol Endocrinol; 2000 Jun; 14(3):173-81. PubMed ID: 10923278
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A comparison of the psychological and hormonal factors in women with and without premenstrual syndrome.
    Trunnell EP; Turner CW; Keye WR
    J Abnorm Psychol; 1988 Nov; 97(4):429-36. PubMed ID: 3204228
    [No Abstract]   [Full Text] [Related]  

  • 68. Dydrogesterone in the treatment of the premenstrual syndrome.
    Kerr GD; Day JB; Munday MR; Brush MG; Watson M; Taylor RW
    Practitioner; 1980 Aug; 224(1346):852-5. PubMed ID: 7001428
    [No Abstract]   [Full Text] [Related]  

  • 69. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.
    Hood SJ; Taylor KP; Ashby MJ; Brown MJ
    Circulation; 2007 Jul; 116(3):268-75. PubMed ID: 17606839
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Possible new relief for premenstrual syndrome.
    Simmons MK
    JAMA; 1983 Sep; 250(11):1371, 1375. PubMed ID: 6684187
    [No Abstract]   [Full Text] [Related]  

  • 71. Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group.
    Steiner M; Steinberg S; Stewart D; Carter D; Berger C; Reid R; Grover D; Streiner D
    N Engl J Med; 1995 Jun; 332(23):1529-34. PubMed ID: 7739706
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder.
    Freeman EW; Kroll R; Rapkin A; Pearlstein T; Brown C; Parsey K; Zhang P; Patel H; Foegh M;
    J Womens Health Gend Based Med; 2001; 10(6):561-9. PubMed ID: 11559453
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Alprazolam in the treatment of premenstrual syndrome. A double-blind, placebo-controlled trial.
    Schmidt PJ; Grover GN; Rubinow DR
    Arch Gen Psychiatry; 1993 Jun; 50(6):467-73. PubMed ID: 8498881
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The treatment of premenstrual symptoms.
    Clare AW
    Br J Psychiatry; 1979 Dec; 135():576-9. PubMed ID: 575303
    [No Abstract]   [Full Text] [Related]  

  • 75. FSH, LH, TeBG-capacity, estrogen and progesterone in women with premenstrual tension during the luteal phase.
    Bäckström T; Wide L; Södergård R; Carstensen H
    J Steroid Biochem; 1976; 7(6-7):473-6. PubMed ID: 987514
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Ineffectiveness of progesterone suppository treatment for premenstrual syndrome.
    Freeman E; Rickels K; Sondheimer SJ; Polansky M
    JAMA; 1990 Jul; 264(3):349-53. PubMed ID: 2194047
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Mefenamic acid in the treatment of premenstrual syndrome.
    Mira M; McNeil D; Fraser IS; Vizzard J; Abraham S
    Obstet Gynecol; 1986 Sep; 68(3):395-8. PubMed ID: 3526218
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effect of doxycycline on pre-menstrual syndrome: a double-blind randomized clinical trial.
    Toth A; Lesser ML; Naus G; Brooks C; Adams D
    J Int Med Res; 1988; 16(4):270-9. PubMed ID: 3049185
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Hormonal and biochemical profiles of premenstrual syndrome. Treatment with essential fatty acids.
    Cerin A; Collins A; Landgren BM; Eneroth P
    Acta Obstet Gynecol Scand; 1993 Jul; 72(5):337-43. PubMed ID: 8392261
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Hormones and electrolytes in premenstrual syndrome.
    Varma TR
    Int J Gynaecol Obstet; 1984 Feb; 22(1):51-8. PubMed ID: 6144593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.